Inside Kyron.bio’s Bold Bet to Rewrite the Rules of Antibody Drug Design
For all the buzz around antibody therapies, one overlooked culprit keeps holding them back: sugars. Paris-based Kyron.bio is tackling the hidden complexity of glycosylation — the way sugars attach to therapeutic proteins — with a platform that promises safer, longer-lasting drugs.
Related
Inside TiHive: How a French Deeptech Startup Is Revolutionizing Quality Control, One Diaper at a Time
The Grenoble-based company just raised €8M to scale its terahertz-AI technology that can see inside products on production lines
C4 Ventures Bets €100M on Europe’s AI Future: New Fund and Partner to Challenge Silicon Valley & China
Paris-based C4 Ventures launches its third €100M fund and adds deep tech investor Valère Rames, underscoring its conviction that Europe can build world-class AI, quantum, and robotics companies despite a tough VC climate.
Phenix and the Fight Against Food Waste: Scaling Passion into Impact
From leftover baguettes to unsold biscuits, Phenix is proving food waste can fuel growth. With 75M meals saved in 2024 and 16,000 stores onboard, CEO Simon Baldeyrou is scaling passion (and plenty of croissants) into Europe’s fight for zero waste.
Europe’s Secret Sovereignty Weapon Against China: Recycled Magnets From MagREEsource
From old e-scooters to wind turbines, a Grenoble-based startup is recycling rare earth magnets to cut Europe’s 98% dependence on China. With tech born in the lab and backed by millions in funding, MagREEsource is turning waste into Europe’s path to sovereignty and sustainability.
Latest
Inside TiHive: How a French Deeptech Startup Is Revolutionizing Quality Control, One Diaper at a Time
The Grenoble-based company just raised €8M to scale its terahertz-AI technology that can see inside products on production lines
La Machine #44: A €100M AI Fund To Defy Silicon Valley's Siren Song
C4 Ventures launches a €100M fund as French AI startups raise €30M+ across 8 deals, from Juisci's medical research platform to Chat3D's generative models. Yet Gigi and Rippletide still decamp for Silicon Valley despite strong European momentum.
C4 Ventures Bets €100M on Europe’s AI Future: New Fund and Partner to Challenge Silicon Valley & China
Paris-based C4 Ventures launches its third €100M fund and adds deep tech investor Valère Rames, underscoring its conviction that Europe can build world-class AI, quantum, and robotics companies despite a tough VC climate.
How Juisci Is Using AI to Save Doctors 8 Hours a Week and Fight Medical Misinformation
French startup Juisci just raised €5.5M to help 200,000+ doctors cut through the flood of medical research. Its AI app turns dense PDF studies into bite-sized insights, saving hours each week and fighting disinformation. Science, served up like Spotify.